News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Press releases 2 Feb 2023 Dutch government renews support to DNDi projects on poverty-related diseases that disproportionately impact women
Press releases 14 Dec 2022 Launch of first platform for emergency research preparedness and response in Africa
Press releases 1 Dec 2022 DNDi partners in a new NIHR-funded Global Health Research Group on HIV-associated Fungal Infections (IMPRINT)
Press releases 30 Nov 2022 Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa
Press releases 15 Nov 2022 Leishmaniasis project launched in Eastern Africa to improve patient access to treatments
Press releases 6 Oct 2022 Le Canton de Genève soutient la recherche sur le mycétome, l’une des maladies les plus négligées au monde
Press releases 29 Sep 2022 Better, shorter combination treatment for people with visceral leishmaniasis shown to be effective in Eastern Africa
Press releases 5 Sep 2022 Dr Luis Pizarro becomes new Executive Director of the Drugs for Neglected Diseases initiative
Press releases 30 Aug 2022 Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and DNDi to explore joint opportunities to develop affordable and life-saving new drugs for neglected tropical diseases
Press releases 3 Aug 2022 Network of experts calls for urgent boost to research and development of rapid tests for cutaneous leishmaniasis in Latin America
Press releases 27 Jul 2022 Korean cutting-edge technology to reduce the cost of promising drug for neglected disease visceral leishmaniasis
Press releases 6 Jul 2022 Wellcome renews partnership with DNDi to develop new generation drugs to treat leishmaniasis
Press releases 5 Jul 2022 Brazil joins ANTICOV trial to find early treatments for people with mild-to-moderate COVID-19
Press releases 29 Jun 2022 DNDi welcomes new PAHO recommendations for the treatment of leishmaniasis in the Americas
Press releases 14 Jun 2022 Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa
Press releases 8 Jun 2022 New WHO treatment guidelines offer hope for people co-infected with visceral leishmaniasis and HIV
